Pathways of Acetyl-CoA Metabolism Involved in the Reversal of Palmitate-Induced Glucose Production by Metformin and Salicylate

 

 Buy Article Permissions and Reprints

Abstract

The pathways through which fatty acids induce insulin resistance have been the subject of much research. We hypothesise that by focussing on the reversal of insulin resistance, novel insights can be made regarding the mechanisms by which insulin resistance can be overcome. Using global gene and lipid expression profiling, we aimed to identify biological pathways altered during the prevention of palmitate-induced glucose production in hepatocytes using metformin and sodium salicylate. FAO hepatoma cells were treated with palmitate (0.075 mM, 48 h) with or without metformin (0.25 mM) and sodium salicylate (2 mM) in the final 24 h of palmitate treatment, and effects on glucose production were determined. RNA microarray measurements followed by gene set enrichment analysis were performed to investigate pathway regulation. Lipidomic analysis and measurement of secreted bile acids and cholesterol were also performed. Reversal of palmitate-induced glucose production by metformin and sodium salicylate was characterised by co-ordinated down-regulated expression of pathways regulating acetyl-CoA to cholesterol and bile acid biosynthesis. All 20 enzymes that regulate the conversion of acetyl-CoA to cholesterol were reduced following metformin and sodium salicylate. Selected findings were confirmed using primary mouse hepatocytes. Although total intracellular levels of diacylglycerol, triacylglycerol and cholesterol esters increased with palmitate, these were not, however, further altered by metformin and sodium salicylate. 6 individual diacylglycerol, triacylglycerol and cholesterol ester species containing 18:0 and 18:1 side-chains were reduced by metformin and sodium salicylate. These results implicate acetyl-CoA metabolism and C18 lipid species as modulators of hepatic glucose production that could be targeted to improve glucose homeostasis.

^* Current address: RMIT University, Level 2, 110 Victoria Street, Melbourne Vic 3001, Australia

^** Current address: Medicines Development for Global Health, Level 1 18 Kavanagh Street, Southbank, VIC 3006, Australia

• References

• 1 Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999; 274: 24202-24210
  CrossrefPubMedGoogle Scholar
• 2 Barma P, Bhattacharya S, Bhattacharya A et al. Lipid induced overexpression of NF-kappaB in skeletal muscle cells is linked to insulin resistance. Biochim Biophys Acta 2009; 1792: 190-200
  CrossrefPubMedGoogle Scholar
• 3 Bilan PJ, Samokhvalov V, Koshkina A et al. Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. Arch Physiol Biochem 2009; 115: 176-190
  CrossrefPubMedGoogle Scholar
• 4 Thrush AB, Heigenhauser GJ, Mullen KL et al. Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1205-R1212
  CrossrefPubMedGoogle Scholar
• 5 Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461
  CrossrefPubMedGoogle Scholar
• 6 Raddatz K, Turner N, Frangioudakis G et al. Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice. Diabetologia 2011; 54: 1447-1456
  CrossrefPubMedGoogle Scholar
• 7 Samuel VT, Liu ZX, Wang A et al. Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 2007; 117: 739-745
  CrossrefPubMedGoogle Scholar
• 8 Jornayvaz FR, Birkenfeld AL, Jurczak MJ et al. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. Proc Nat Acad Sci USA 2011; 108: 5748-5752
  CrossrefPubMedGoogle Scholar
• 9 Turpin E, Russomarie F, Dubois T et al. In adrenocortical tissue, annexins ii and vi are attached to clathrin coated vesicles in a calcium-independent manner. Biochim Biophys Acta 1998; 1402: 115-130
  CrossrefPubMedGoogle Scholar
• 10 Raichur S, Wang ST, Chan PW et al. CerS2 Haploinsufficiency Inhibits beta-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance. Cell Metab 2014; 20: 687-695
  CrossrefPubMedGoogle Scholar
• 11 Nakamura S, Takamura T, Matsuzawa-Nagata N et al. Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria. J Biol Chem 2009; 284: 14809-14818
  CrossrefPubMedGoogle Scholar
• 12 Cai DS, Yuan MS, Frantz DF et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappa B. Nat Med 2005; 11: 183-190
  CrossrefPubMedGoogle Scholar
• 13 Arkan MC, Hevener AL, Greten FR et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005; 11: 191-198
  CrossrefPubMedGoogle Scholar
• 14 Hage Hassan R, Hainault I, Vilquin JT et al. Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells. Diabetologia 2012; 55: 204-214
  CrossrefPubMedGoogle Scholar
• 15 Monetti M, Levin MC, Watt MJ et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007; 6: 69-78
  CrossrefPubMedGoogle Scholar
• 16 Deevska GM, Rozenova KA, Giltiay NV et al. Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice. J Biol Chem 2009; 284: 8359-8368
  CrossrefPubMedGoogle Scholar
• 17 Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24-27
  CrossrefPubMedGoogle Scholar
• 18 Foletta VC, Prior MJ, Stupka N et al. NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol 2009; 587: 1619-1634
  CrossrefPubMedGoogle Scholar
• 19 Carey KA, Segal D, Klein R et al. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays. Pathol Int 2006; 56: 246-255
  CrossrefPubMedGoogle Scholar
• 20 Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 1969; 43: 506-520
  CrossrefPubMedGoogle Scholar
• 21 Achouri Y, Hegarty BD, Allanic D et al. Long chain fatty acyl-CoA synthetase 5 expression is induced by insulin and glucose: involvement of sterol regulatory element-binding protein-1c. Biochimie 2005; 87: 1149-1155
  CrossrefPubMedGoogle Scholar
• 22 Weir JM, Wong G, Barlow CK et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res 2013; 54: 2898-2908
  CrossrefPubMedGoogle Scholar
• 23 Boslem E, MacIntosh G, Preston AM et al. A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 2011; 435: 267-276
  CrossrefPubMedGoogle Scholar
• 24 Ford RJ, Fullerton MD, Pinkosky SL et al. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. Biochem J 2015; 468: 125-132
  CrossrefPubMedGoogle Scholar
• 25 Salomaki H, Heinaniemi M, Vahatalo LH et al. Prenatal metformin exposure in a maternal high fat diet mouse model alters the transcriptome and modifies the metabolic responses of the offspring. PLoS One 2014; 9: e115778
  CrossrefPubMedGoogle Scholar
• 26 Nakamura S, Takamura T, Matsuzawa-Nagata N et al. Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria. Journal of Biological Chemistry 2009; 284: 14809-14818
  CrossrefPubMedGoogle Scholar
• 27 Cipriani S, Mencarelli A, Palladino G et al. activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res 2010; 51: 771-784
  CrossrefPubMedGoogle Scholar
• 28 Li TG, Owsley E, Matozel M et al. Transgenic expression of cholesterol 7 alpha-hydroxylase in the liver prevents high-fat diet induced obesity and insulin resistance in mice. Hepatology 2010; 52: 678-690
  CrossrefPubMedGoogle Scholar
• 29 Sato R. Sterol metabolism and SREBP activation. Arch Biochem Biophys 2010; 501: 177-181
  CrossrefPubMedGoogle Scholar
• 30 Kliewer SA, Sundseth SS, Jones SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 1997; 94: 4318-4323
  CrossrefPubMedGoogle Scholar
• 31 Minehira K, Young SG, Villanueva CJ et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J Lipid Res 2008; 49: 2038-2044
  CrossrefPubMedGoogle Scholar
• 32 Liu X, Xue Y, Liu C et al. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health Dis 2013; 12: 109
  CrossrefPubMedGoogle Scholar
• 33 Guillou H, Zadravec D, Martin PG et al. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res 2010; 49: 186-199
  CrossrefPubMedGoogle Scholar
• 34 Matsuzaka T, Shimano H. Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med 2009; 87: 379-384
  CrossrefPubMedGoogle Scholar
• 35 Moon YA, Ochoa CR, Mitsche MA et al. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance. J Lipid Res 2014; 55: 2597-2605
  CrossrefPubMedGoogle Scholar
• 36 Zhang Y, Hu C, Hong J et al. Lipid profiling reveals different therapeutic effects of metformin and glipizide in patients with type 2 diabetes and coronary artery disease. Diabetes Care 2014; 37: 2804-2812
  CrossrefPubMedGoogle Scholar
• 37 Jornayvaz FR, Shulman GI. Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab 2012; 15: 574-584
  CrossrefPubMedGoogle Scholar
• 38 Schmitz-Peiffer C, Biden TJ. Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 2008; 57: 1774-1783
  CrossrefPubMedGoogle Scholar
• 39 Sung M, Kim I, Park M et al. Differential effects of dietary fatty acids on the regulation of CYP2E1 and protein kinase C in human hepatoma HepG2 cells. J Med Food 2004; 7: 197-203
  CrossrefPubMedGoogle Scholar
• 40 Mori T, Takai Y, Yu B et al. Specificity of the fatty acyl moieties of diacylglycerol for the activation of calcium-activated, phospholipid-dependent protein kinase. J Biochem Toxicol 1982; 91: 427-431
  PubMedGoogle Scholar
• 41 Cazzolli R, Craig DL, Biden TJ et al. Inhibition of glycogen synthesis by fatty acid in C2C12 muscle cells is independent of PKC-α , -ε , and -θ. Am J Physiol 2002; 282: E1204-E1213
  PubMedGoogle Scholar
• 42 Barritt G. Pyruvate Carboxylase. In: Wallace J, Keech DB. eds. Pyruvate Carboxylase. Boca Raton: CRC Press; 1985: 141-177
  Google Scholar
• 43 Rebrin K, Steil GM, Mittelman SD et al. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 1996; 98: 741-749
  CrossrefPubMedGoogle Scholar
• 44 Sindelar DK, Chu CA, Rohlie M et al. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 1997; 46: 187-196
  CrossrefPubMedGoogle Scholar
• 45 Staehr P, Hother-Nielsen O, Landau BR et al. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 2003; 52: 260-267
  CrossrefPubMedGoogle Scholar
• 46 Perry RJ, Camporez JP, Kursawe R et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015; 160: 745-758
  CrossrefPubMedGoogle Scholar

• Supplementary Material